What we're reading, March 29, 2016: the Obama administration is expected to announce new measures to combat opioid addiction; cholesterol test results from Theranos could throw off doctors' decisions; and Republicans aren't talking as much about Obamacare on the campaign trail.
With the opioid epidemic receiving more and more attention in the US, the Obama administration plans to unveil measures to help combat the issue. The president plans to increase access to a medication that combats drug addiction by allowing qualified physicians to prescribe the drug to twice as many patients as they are currently allowed, according to STAT. In addition, Obama is reportedly creating a task force to advance access to mental health and substance use disorder treatment.
Doctors might want to get a second opinion if they base medical decisions on cholesterol tests done by Theranos Inc. According to The Wall Street Journal, Theranos’ results for total cholesterol were lower by 9.3% on average compared with the 2 largest laboratory companies in the US. Researchers from Mount Sinai discovered the discrepancy and published their results in the Journal of Clinical Investigation. They wrote that the average gap could lead doctors to “either inappropriately initiate or fail to appropriately initiate statin therapy.”
Republicans may not like President Obama’s Affordable Care Act, but they aren’t talking much about it any more. This election year, Republican candidates are not allowing talk of replacing Obamacare to dominate the dialogue, and neither party is viewing healthcare reform as a top issue, reported The New York Times. The reason is simple: despite its controversy, the law has taken hold with some impressive numbers. Republicans have even admitted that they would keep certain popular provisions.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen